NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors-Reference-Cited by-同舟云学术

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors

Published:2017-05-19 Issue: Volume: Page:e1330235
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

MacFarlane Alexander W.¹,Jillab Mowafaq¹²,Smith Mitchell R.³,Alpaugh R. Katherine³^ORCID,Cole Marion E.³,Litwin Samuel⁴,Millenson Michael M.³,Al-Saleem Tahseen²,Cohen Adam D.³,Campbell Kerry S.¹^ORCID

Affiliation:

1. Blood Cell Development and Function Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA

2. Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA

3. Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

4. Bioinformatics and Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1330235

Reference64 articles.

1. Chronic lymphocytic leukemia (CLL)-Then and now

2. Cancer statistics, 2015

3. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

4. Expression of the Chemokine Receptors CXCR4 and CCR7 and Disease Progression in B-Cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotyping of Peripheral Blood Cells in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib;Cells;2024-08-30

2. Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis;Expert Opinion on Pharmacotherapy;2024-07-23

3. In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors;OncoImmunology;2024-07-18

4. The KIR2DL family serves as prognostic biomarkers and correlates with immune infiltrates in acute myeloid leukaemia;Journal of Cellular and Molecular Medicine;2024-03-25

5. Cutaneous malignancies in chronic lymphocytic leukemia;The Journal of Dermatology;2024-01-31